Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line

Endocrinology. 1994 May;134(5):2011-7. doi: 10.1210/endo.134.5.8156901.

Abstract

Studies on the cholinergic regulation of intestinal L-cells have been focused on the release of enteroglucagon, but the signal transduction pathways were not defined. These were here investigated by using as index the release of immunoreactive glucagon-like peptide-1 (GLP-1) from the endocrine cell line STC-1, that has been shown to contain proglucagon mRNA transcripts. Abundant GLP-1 immunoreactivity was revealed in STC-1 cells at immunocytochemistry and by RIA. The cell content was 4927 +/- 689 pg/10(6) cells, as measured with antiserum 199D that recognizes specifically the C-terminal amidated forms of GLP-1. The secretion of GLP-1 over a 2-h incubation period amounted to 1.4 +/- 0.3% of the total GLP-1 cell content and was significantly increased by 10 microM forskolin and 100 nM 12-O-tetradecanoylphorbol 13-acetate to 206% and 574% of control values, respectively. The cholinergic agonist carbachol stimulated GLP-1 secretion in a concentration-dependent manner, maximal release was observed at 1 mM carbachol (228% of the control value). Binding of the muscarinic antagonist [N-methyl-]scopolamine ([3H]NMS) on cell homogenates was time dependent, specific, and saturable. Scatchard analysis revealed one class of receptors (Kd, 14 pM; binding capacity, 20 fmol/mg protein). Carbachol (0.1 microM to 1 mM) dose dependently displaced [3H] NMS binding and increased the intracellular calcium concentration without modification of adenylate cyclase activity. The order of potency of different antagonists, showing a preferential affinity for M1, M2, and M3 muscarinic receptor subtypes, to inhibit [3H]NMS binding, the carbachol-induced increase in intracellular calcium, and carbachol-stimulated GLP-1 secretion, was as follows: atropine (nonselective) > 4-diphenylacetoxy-N-methylpiperidine methiodide (M3) > pirenzepine (M1) > AF-DX 116 (M2). The results of the present study, therefore, demonstrate that secretion of GLP-1 induced by cholinergic agonist depends on muscarinic M3-subtype receptors in the endocrine intestinal cell line STC-1. This system may prove useful to study the cellular mechanisms of GLP-1 secretion.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / metabolism
  • Carbachol / pharmacology
  • Cell Line
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism
  • Endocrine Glands / drug effects
  • Endocrine Glands / metabolism*
  • Glucagon / metabolism*
  • Glucagon-Like Peptide 1
  • Intestinal Mucosa / metabolism*
  • Intestines / drug effects
  • Kinetics
  • Muscarinic Antagonists
  • N-Methylscopolamine
  • Parasympathomimetics / pharmacology*
  • Peptide Fragments / metabolism*
  • Protein Precursors / metabolism*
  • Receptors, Muscarinic / drug effects
  • Receptors, Muscarinic / physiology*
  • Scopolamine Derivatives / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Muscarinic Antagonists
  • Parasympathomimetics
  • Peptide Fragments
  • Protein Precursors
  • Receptors, Muscarinic
  • Scopolamine Derivatives
  • Colforsin
  • Glucagon-Like Peptide 1
  • Carbachol
  • Glucagon
  • Cyclic AMP
  • Tetradecanoylphorbol Acetate
  • Calcium
  • N-Methylscopolamine